The hypnotic actions of the fatty acid amide, oleamide

Neuropsychopharmacology

Volumn 25, Issue 5, 2001, Pages S36-S39

  Mendelson, Wallace B ^a   Basile, Anthony S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Fatty acids; Hypnotics; Oleamide; Sleep

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMIDE; CANNABINOID RECEPTOR ANTAGONIST; ENZYME; FATTY ACID; FATTY ACID AMIDASE; FATTY ACID DERIVATIVE; HYPNOTIC AGENT; KETONE DERIVATIVE; LOH 1151; OLEAMIDE; RIMONABANT; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; TRIAZOLAM; TRIFLUOROMETHYLOCTADECENONE; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ARTICLE; CEREBROSPINAL FLUID; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; FATTY ACID SYNTHESIS; MAMMAL; NERVE FUNCTION; NERVOUS SYSTEM; NONHUMAN; PLASMA; PRIORITY JOURNAL; SLEEP DEPRIVATION; SLEEP INDUCTION; SLEEP TIME;

ANIMALS; BRAIN; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HYPNOTICS AND SEDATIVES; OLEIC ACIDS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SEROTONIN; SLEEP;

EID: 0034771517     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00341-4     Document Type: Article

References (27)

1. Arafat ES, Trimble JW, Andersen RN, Dass C, Desiderio DM (1989): Identification of fatty acid amides in human plasma. Life Sci 45:1679-1687
2. Basile A, Hanus L, Mendelson WB (1999): Characterization of the hypnotic properties of oleamide. NeuroReport 10:947-951
3. Bolger DL, Patterson JE, Jin Q (1998): Structural require-ments for 5-HT2a and 5-HT1a serotonin receptor potentiation by the biologically active lipid oleamide. PNAS 95:4102-4107
4. Cooper I, Lord T, Tice PA (1995): Hydrolysis studies on oleamide in simulated gastrointestinal fluids. Food AdditContam 12:769-777
5. Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Hen-riksen SJ, Boger DL, Lerner RA (1995): Chemical charac-terization of a family of brain lipids that induce sleep. Science 268:1506-1508
6. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992): Isolation and structure of a brain constituent that binds to the cannabinoid receptor [see comments]. Science 258:1946-1949
7. Ha J-H, Basile AS (1996): Modulation of ligand binding to components of the GABAA receptor complex by ammo-nia: implications for the pathogenesis of hyperammone-mic syndromes. Brain Res 720:35-44
8. Hauer KL, Bakhshan F, Lin H, Pidgeon C, Barker EL (1998): The sleep inducing lipid oleamide can potentiate the endogenous cannabinoid anandamide by transport inhibition. ACNP Annual Meeting, Las Colinas, Puerto Rico Abstract: 150
9. Hebbeln JR, Salem N (1999): Dietary polyunsaturated fats and depression: when cholesterol does not satisfy. Am J ClinNutr 61:1-9
10. Huang R-Q, Dillon GH (1998): Maintenance of recombinant type A g-aminobutyric acid receptor function: role of protein tyrosine phosphorylation and calcineurin. JPET 286:243-255
11. Huidobro-Toro JP, Harris RA (1996): Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. ProcNatlAcadSci 93:8078-8082
12. Leidenheimer NJ, Browning MD, Harris RA (1991): GABAareceptor phosphorylation: multiple sites, actions and artifacts. TIPS 12:84-87
13. Lerner RA, Siuzdak G, Prospero-Garcia O, Henriksen SJ, Boger DL, Cravatt BF (1994): Cerebrodiene: A brain lipid isolated from sleep deprived cats. ProcNatlAcad Sci USA 91:9505-9508
14. Maes M, Smith RS (1998): Fatty acids, cytokines and major depression. Biol Psychiatry 43:313-314
15. Mechoulam R, Fride E, Hanus L, Sheskin T, Di Marzo V, Bayewitch M, Vogel Z (1997): Anandamide may medi-ate sleep induction [letter]. Nature 389:25-26
16. Mendelson WB, Basile AS (1999): The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. NeuroReport 10:3237-3239
17. Mendelson WB, Basile AS (2000a) Sleep-inducing effects of oleamide in mice. 15th Congress of European Sleep Research Society Istanbul, September. 12-16
18. Mendelson WB, Basile AS (2000b): Synergistic interaction of the hypnotic effects of oleamide and triazolam. Sleep 23 (suppl 2):A162
19. Mendelson WB, Hanus L, Basile AS (2000c): The hypnotic effects of LOH-1-151, an inhibitor of oleamidecatabo-lism. Sleep 23(suppl 2):A163
20. Meves H (1994): Modulation of ion channels by arachidonic acid. ProgNeurobiol 43:175-186
21. Peet M, Murhphy B, Shay J, Horrobin D (1998): Depletion of omega-3 fatty acid levels in red blood cell mem-branes of depressive patients. BiolPsychiat 43:315-319
22. Santucci V, Storme JJ, Soubrie P (1996): Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716 A in rats as assessed by electroencephalo-graphic spectral and sleep-waking cycle analysis. Life Sci 58:PL103-PL110
23. Sugiura T, Kondo S, Kodaka T (1996): Enzymatic symthesis of oleamide (cis-9, 10-octadecenoamide), an endoge-nous sleep-inducing lipid, by rat brain microsomes. Bio-chemMolBiolInt 40:931-938
24. Terranova J-P, Storme J-J, Lafon N, Perio A, Rinaldi-Car-mina M, Le Fur G, Soubrie P (1996): Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126:165-172
25. Thomas EA, Carson MJ, Neal MJ, Sutcliffe JG (1997): Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. ProcNatl AcadSci USA 94:14115-14119
26. Witt M-R, Nielsen M (1994): Characterization of the influ-ence of unsaturated free fatty acids on brain GABAben-zodiazepine receptor binding in vitro. J Neurochem 62:1432-1439
27. Yost CS, Leonoudakis BS, Koblin DD, Bornheim LM, Hamp-son AJ, Gray AT (1998): Oleic amide potentiates benzo-diazepine-sensitive GABAa receptor activity but does not alter MAC. Anaesthesia and Analgesia 86:1294-1300